Radio and PodcastRadio and PodcastLive Radio & Podcasts
Ep. 373 - AbbVie M&A, FDA reversals, a CAR T first artwork
Science & Medicine

Ep. 373 - AbbVie M&A, FDA reversals, a CAR T first

BioCentury This Week by BioCentury

Jun 22, 202630:10Science & Medicine

AbbVie's $10.9 billion deal to acquire Apogee will expand its immunology pipeline by delivering assets for atopic dermatitis and asthma. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the takeo...

About This Episode

Ep. 373 - AbbVie M&A, FDA reversals, a CAR T first is an episode from BioCentury This Week by BioCentury. AbbVie's $10.9 billion deal to acquire Apogee will expand its immunology pipeline by delivering assets for atopic dermatitis and asthm...

Podcast

This episode belongs to BioCentury This Week.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 22, 2026, 30:10 long, audio available.

Related Episodes

Continue listening to more episodes from BioCentury This Week.